EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Mitochondria‐Damaging Self‐Reporting Probe for Cancer Therapy

Hai Xu iD, Yura Lee, Sanghee Yoon iD, Yun Wang, Yejin Cho, Seongyu Choi, Lu Lu, Hua Zhang iD, Sun Choi iD, Ki Taek Nam iD, Juyoung Yoon iD

Angewandte Chemie International Edition · 2026

DOI: 10.1002/anie.8302619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Hai Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Mitochondria, Antineoplastic Agents, Fluorescent Dyes, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, National Natural Science Foundation of China, Korea Basic Science Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial damage induced by chemotherapeutic agents through disruption of the mitochondrial membrane potential (Δ Ψ m ) remains a central challenge in drug development and evaluation. However, the assessment of Δ Ψ m ‐targeting drugs using commercially available fluorescent probes is often unreliable, as these dyes can interfere with, mask, or artificially amplify drug‐induced mitochondrial dysfunction, frequently resulting in misleading conclusions and translational failure. Herein, we report a class of cationic chemotherapeutic small molecules ( DPPs ) possessing intrinsic fluorescence migration‐based self‐reporting capability, which enables direct and non‐invasive monitoring of drug action without the need for external probes. Among them, DPP‐1 and DPP‐2 disrupt mitochondrial function, trigger excessive reactive oxygen species generation, and induce highly selective apoptosis. Remarkably, both compounds exhibit concentration‐dependent mitochondrial‐to‐nuclear translocation, enabling the real‐time visualization of therapeutic progression at the subcellular level. In vivo studies further confirm their potent tumor growth inhibition and negligible systemic toxicity effects. This self‐reporting mitochondria‐targeted chemotherapeutic platform provides a highly promising strategy for integrated cancer diagnosis and precision therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaAntineoplastic AgentsFluorescent DyesNeoplasmsHumansAnimalsMembrane Potential, MitochondrialApoptosisReactive Oxygen SpeciesFluorescent Chemosensor CompoundsMiceDrug Screening Assays, Antitumor

Stichwörter der Autor:innen

cancer therapyfluorescence imagingmitochondriaself‐reporting probe

Substanzen

Antineoplastic AgentsFluorescent DyesReactive Oxygen SpeciesFluorescent Chemosensor Compounds

Autor:innen und Institutionen

  • Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, Republic of Korea.
  • Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Global AI Drug Discovery Center, College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.
  • Laboratory of Human Disease and Immunotherapies, West China Hospital, Sichuan University, Chengdu, P. R. China.
  • School of Chemistry and Chemical Engineering, Henan International Joint Laboratory of Smart Molecules and Identification and Diagnostic Functions, Henan Normal University, Henan, P. R. China.
  • Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea.

ORCID-Profile: Hai Xu, Sanghee Yoon, Hua Zhang, Sun Choi, Ki Taek Nam, Juyoung Yoon

Förderung

  • National Research Foundation of Korea
  • National Natural Science Foundation of China
  • Korea Basic Science Institute

Zitieren

APA

Xu, H., Lee, Y., Yoon, S., Wang, Y., Cho, Y., Choi, S., Lu, L., Zhang, H., Choi, S., Nam, K. T., & Yoon, J. (2026). Mitochondria‐Damaging Self‐Reporting Probe for Cancer Therapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.8302619

Vancouver

Xu H, Lee Y, Yoon S, Wang Y, Cho Y, Choi S, et al. Mitochondria‐Damaging Self‐Reporting Probe for Cancer Therapy. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.8302619

BibTeX
@article{Xu2026,
  author = {Xu, Hai and Lee, Yura and Yoon, Sanghee and Wang, Yun and Cho, Yejin and Choi, Seongyu and Lu, Lu and Zhang, Hua and Choi, Sun and Nam, Ki Taek and Yoon, Juyoung},
  title = {Mitochondria‐Damaging Self‐Reporting Probe for Cancer Therapy},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  doi = {10.1002/anie.8302619}
}
Kostenlos starten →